News & Updates
Filter by Specialty:
Lenvatinib-pembrolizumab combo fails to spring forward in HCC treatment
19 Oct 2022
byAudrey Abella
In the phase III LEAP*-002 study, a combination regimen comprising lenvatinib and pembrolizumab appeared to have similar efficacy and safety as lenvatinib monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC).
Lenvatinib-pembrolizumab combo fails to spring forward in HCC treatment
19 Oct 2022
Mitokine levels predict COPD outcomes
19 Oct 2022
In patients with chronic obstructive pulmonary disease (COPD), mitokine levels are elevated and are associated with important clinical outcomes such as disease exacerbation and exercise capacity, a recent study has found.
Mitokine levels predict COPD outcomes
19 Oct 2022
Vitamin A intake helps prevent diabetes onset in adults
18 Oct 2022
People who have enough vitamin A intake are less likely to develop diabetes, and this benefit is more pronounced among men, reports a study of Chinese adults with plant-based diets.
